OncoGenex Hires Advisor, Evaluates Options As Cancer Drug Fails Again - Xconomy

Fox News

OncoGenex Hires Advisor, Evaluates Options As Cancer Drug Fails Again Xconomy It wasn't too long ago that OncoGenex had high hopes that a drug called custirsen might make a big impact on the fast-moving treatment landscape for prostate cancer. A few failed trials later, however, the Bothell, WA, company has now hired a financial ... OncoGenex seeks strategic alternatives after drug study failsReuters OncoGenex's custirsen flunks late-stage study in prostate cancer; shares slump 34% premarketSeeking Alpha OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI): Consensus Estimates in ViewPress Telegraph FTSE News all 9 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNGlhvi3LVr9MK-e-DgKs-TkrkGqRw&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779182805965&ei=NAOzV4B9xc_cAbnihNAK&url=http://www.xconomy.com/seattle/2016/08/16/oncogenex-hires-banker-evaluates-options-as-cancer-drug-fails-again/
via IFTTT